Ozempic for All
An estimated 100 million adult Americans—more than 40 percent of the population—are classified as obese. This is a massive health crisis that will claim many lives over the next decades. As is well known, drugs now exist that can dramatically reduce obesity and its related health risks. But most of the roughly 37 million adult […]
What FEHB changes mean for your 2026 health coverage
<![CDATA[ Most federal employees and retirees will pay much more for health coverage next year; the enrollee share of premium is going up 12.3% on average. OPM cites an aging federal workforce with more chronic conditions and prescription drug usage, including GLP-1 medications prescribed for weight loss, as contributors to the premium increase. How will […]
GLP-1 Weight-loss Drugs May Reduce Alcohol Cravings
Post Content
Novo Secures Cardiovascular Expansion for Semaglutide Pill
Rybelsus can now be used as a primary or secondary prevention pill to lower the risk of major adverse cardiovascular events in at-risk patients with type 2 diabetes.
Mounjaro: What is the ‘golden dose’ and what are the risks?
Post Content
Head of addiction medicine society warns of treatment cuts and rising threat of gambling
BOSTON — The president of a leading addiction medicine group issued stark warnings on hardline Trump administration policies on substance use, low rates of addiction treatment uptake, and a rise in problem gambling. But Stephen Taylor, the president of the American Society of Addiction Medicine, tempered his remarks with optimism. In particular, he expressed hope […]
Novo GLP-1 pill OK’d in U.S. for heart disease risk (NVO:NYSE) – Seeking Alpha
Novo GLP-1 pill OK’d in U.S. for heart disease risk (NVO:NYSE) Seeking Alpha FDA Approves Novo Nordisk’s Rybelsus Diabetes Pill to Reduce Heart Risk The Wall Street Journal First oral GLP-1 cuts cardiovascular risk by 14% – and it’s now FDA-approved New Atlas FDA approves Novo Nordisk’s oral semaglutide for cardiovascular (CV) risk reduction in adults with type […]
How big is the GLP-1 wave going to get, really?
GLP-1 drugs like Ozempic and Wegovy are transforming public health and consumer habits. Here we explore their explosive growth, future potential, and impact on the food industry.
BF Biosciences brings GLP-1 manufacturing to Pakistan
BF Biosciences Ltd has begun local manufacturing of tirzepatide, bringing one of the world’s most sought-after metabolic drugs into production on Pakistani soil. In a material disclosure to the Pakistan Stock Exchange, the company said it has launched Zeptide (tirzepatide) in an easy-to-use pre-filled syringe, produced at its new European-specification pre-filled syringes facility. The company […]
FDA Approves Rybelsus (semaglutide) for Cardiovascular Risk Reduction in Adults with Type 2 Diabetes Who Are at High Risk
PLAINSBORO, N.J. and BAGSVÆRD, Denmark, Oct. 17, 2025 /PRNewswire/ — Novo Nordisk announced today that the US Food and Drug Administration (FDA) has approved Rybelsus, the only oral GLP-1 medication available, for reducing the risk of major…